Abstract
Objective:The aim of this study was to analyze our experience with stereotactic radiosurgery in the management of patients with brain metastases from radioresistant primary cancers.Methods:We retrospectively reviewed the clinical record of those patients for the outcome measures. All data were coded and entered into multivariate regression analysis for studying the relationship between survival and other variables.Results:Over a 48-month period, 31 patients received radiosurgery for brain metastases from renal cell carcinoma (n = 7), malignant melanoma (n = 14), or colon carcinoma (n = 10) at our institution. The followup ranged from 1–48 months (mean = 17 months). At the time of last followup, 11 patients (35.5%) were alive and 20 had died. Six deaths (30%) resulted from progressive brain disease while 14 patients died from progressive primary and/or extracranial metastatic disease. Mean survival from radiosurgery was 12 months (95% CI, 7–17) and the median survival was 7 months. The 1 and 2 year actuarial survival rates were 32.5 ± 1% and 12.2 ± 1% respectively. The overall survival was directly related to tumor control time (P <0.001) and inversely to the number of metastases (P = 0.031).Conclusion:Gamma Knife® stereotactic radiosurgery for intracranial metastases from conventionally radioresistant primary cancers is a safe and effective method to provide better local control of the brain disease and improve survival time.
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
References
References1. Amendola BE, Wolf AL, Coy SR, et al. Brain metastases in renal cell carcinoma: management with gamma knife radiosurgery. Cancer J 2000;6:372–376.AmendolaBE]]WolfAL]]CoySR&etal;Brain metastases in renal cell carcinoma: management with gamma knife radiosurgery.Cancer J20006372-3762. Gerosa M, Nicolato A, Foroni R. The role of gamma knife radiosurgery in the treatment of primary and metastatic brain tumors. Curr Opin Oncol 2003;15:188–196.GerosaM]]NicolatoA]]ForoniRThe role of gamma knife radiosurgery in the treatment of primary and metastatic brain tumors.Curr Opin Oncol200315188-1963. Nussbaum ES, Djalilian HR, Cho KH, et al. Brain metastases: histology, multiplicity, surgery and survival. Cancer 1996;78:1781–1788.NussbaumES]]DjalilianHR]]ChoKH&etal;Brain metastases: histology, multiplicity, surgery and survival.Cancer1996781781-17884. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomized trial. Lancet 2004;363:1665–1672.AndrewsDW]]ScottCB]]SperdutoPW&etal;Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomized trial.Lancet20043631665-16725. Becker G, Duffner F, Kortmann R, et al. Radiosurgery for the treatment of brain metastases in renal cell carcinoma. Anticancer Res 1999;19:1611–1617.BeckerG]]DuffnerF]]KortmannR&etal;Radiosurgery for the treatment of brain metastases in renal cell carcinoma.Anticancer Res1999191611-16176. Brown PD, Brown CA, Pollock BE, et al. Stereotactic radiosurgery for patients with “radioresistant” brain metastases. Neurosurgery 2002;51:656–665; discussion 665–667.7. Chang EL, Selek U, Hassenbusch SJ III, et al. Outcome variation among “radioresistant” brain metastases treated with stereotactic radiosurgery. Neurosurgery 2005;56:936–945.ChangEL]]SelekU]]HassenbuschSJIII&etal;Outcome variation among “radioresistant” brain metastases treated with stereotactic radiosurgery.Neurosurgery200556936-9458. Hernandez L, Zamorano L, Sloan A, et al. Gamma knife radiosurgery for renal cell carcinoma brain metastases. J Neurosurg 2002;97(5 suppl):489–493.HernandezL]]ZamoranoL]]SloanA&etal;Gamma knife radiosurgery for renal cell carcinoma brain metastases.J Neurosurg200297489-4939. Koc M, McGregor J, Grecula J, et al. Gamma Knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors. J Neurooncol 2005;71:307–313.KocM]]McGregorJ]]GreculaJ&etal;Gamma Knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors.J Neurooncol200571307-31310. Petrovich Z, Yu C, Giannotta SL, et al. Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery. J Neurosurg 2002;97(5 suppl):499–506.PetrovichZ]]YuC]]GiannottaSL&etal;Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery.J Neurosurg200297499-50611. Sheehan JP, Sun MH, Kondziolka D, et al. Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control. J Neurosurg 2003;98:342–349.SheehanJP]]SunMH]]KondziolkaD&etal;Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control.J Neurosurg200398342-34912. Vesagas T, Aguilar JA, Mercado ER, et al. Gamma knife radiosurgery and brain metastases: local control, survival, and quality of life. J Neurosurg 2002;97(5 suppl):507–510.VesagasT]]AguilarJA]]MercadoER&etal;Gamma knife radiosurgery and brain metastases: local control, survival, and quality of life.J Neurosurg200297507-51013. Wronski M, Abit E. Surgical treatment of brain metastases from melanoma a retrospective study of 91 patients. J Neurosurg 2000;93:9–18.WronskiM]]AbitESurgical treatment of brain metastases from melanoma a retrospective study of 91 patients.J Neurosurg2000939-1814. Mindermann T. Tumor recurrence and survival following gamma knife surgery for brain metastases. J Neurosurg 2005;102(suppl):287–288.MindermannTTumor recurrence and survival following gamma knife surgery for brain metastases.J Neurosurg2005102287-28815. Kondziolka D, Patel A, Lundsford LD, et al. Stereotactic radiosurgery plus whole brain radiotherapy alone for patients with brain metastases. Int J Radiat Oncol Biol Phys 1999;45:427–434.KondziolkaD]]PatelA]]LundsfordLD&etal;Stereotactic radiosurgery plus whole brain radiotherapy alone for patients with brain metastases.Int J Radiat Oncol Biol Phys199945427-43416. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998;280:1485–1489.PatchellRA]]TibbsPA]]RegineWF&etal;Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.JAMA19982801485-148917. Karim A, Fowler M, Jones L, et al. Cyclooxygenase-2 expression in brain metastases. Anticancer Res 2005;25:2969–2971.KarimA]]FowlerM]]JonesL&etal;Cyclooxygenase-2 expression in brain metastases.Anticancer Res2005252969-297118. Karim A, McCarthy K, Jawahar A, et al. Differential cyclooxygenase-2 enzyme expression in radiosensitive versus radioresistant glioblastoma multiforme cell lines. Anticancer Res 2005;25(1B):675–679.KarimA]]McCarthyK]]JawaharA&etal;Differential cyclooxygenase-2 enzyme expression in radiosensitive versus radioresistant glioblastoma multiforme cell lines.Anticancer Res2005251B675-67919. Mintz AH, Kestle J, Rathbone MP, et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996;78:1470–1476.MintzAH]]KestleJ]]RathboneMP&etal;A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis.Cancer1996781470-147620. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494–500.PatchellRA]]TibbsPA]]WalshJW&etal;A randomized trial of surgery in the treatment of single metastases to the brain.N Engl J Med1990322494-500
